FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)
CUSIP: 31189P102
Q1 2014 13F Holders as of 31 Mar 2014
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 122,342,805
- Total 13F shares
- 9,563,610
- Share change
- +3,149,331
- Total reported value
- $92,835,964
- Price per share
- $9.74
- Number of holders
- 21
- Value change
- +$30,694,357
- Number of buys
- 10
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 31189P102?
CUSIP 31189P102 identifies FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 31189P102:
Top shareholders of FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.98%
|
1,197,200
|
$7,518,000 | — | 31 Dec 2013 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
0.7%
|
861,802
|
$5,412,000 | — | 31 Dec 2013 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.57%
|
702,000
|
$4,409,000 | — | 31 Dec 2013 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.44%
|
544,243
|
$3,418,000 | — | 31 Dec 2013 | |
| Board of Trustees of The Leland Stanford Junior University |
13F
|
Company |
0.25%
|
303,538
|
$1,906,000 | — | 31 Dec 2013 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.17%
|
201,900
|
$1,268,000 | — | 31 Dec 2013 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
40,991
|
$257,000 | — | 31 Dec 2013 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.02%
|
26,201
|
$165,000 | — | 31 Dec 2013 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.02%
|
18,526
|
$116,000 | — | 31 Dec 2013 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.02%
|
18,500
|
$115,000 | — | 31 Dec 2013 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
10,441
|
$66,000 | — | 31 Dec 2013 | |
| UBS AG |
13F
|
Company |
0%
|
1,717
|
$11,000 | — | 31 Dec 2013 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,035
|
$6,000 | — | 31 Dec 2013 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0%
|
1,000
|
$6,000 | — | 31 Dec 2013 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0%
|
99
|
$622 | — | 31 Dec 2013 |
Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q1 2014
As of 31 Mar 2014,
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,563,610 shares.
The largest 10 holders included
FMR LLC, Polaris Venture Management Co. V, L.L.C., WELLINGTON MANAGEMENT CO LLP, KINGDON CAPITAL MANAGEMENT, L.L.C., ORBIMED ADVISORS LLC, Board of Trustees of The Leland Stanford Junior University, FARALLON CAPITAL MANAGEMENT LLC, PRINCIPAL FINANCIAL GROUP INC, VANGUARD GROUP INC, and Bank of New York Mellon Corp.
This page lists
21
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2014 vs Q4 2013 Across Filers
Q4 2013 holders
15
Q1 2014 holders
21
Holder diff
6
| Investor | Q4 2013 Shares | Q1 2014 Shares | Share Diff | Share Chg % | Q4 2013 Value $ | Q1 2014 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.